InvestorsHub Logo

couldbebetter

08/06/21 7:02 PM

#349704 RE: sts66 #349698

Sts66, Where do you see the royalty from HLS being 8%?
From the original agreement it is "tiered double digit royalties"
on net sales.

funnygi2

08/06/21 7:10 PM

#349706 RE: sts66 #349698

"Amarin Corporation Plc - Agreement also provides for HLS to pay Amarin tiered double digit royalties on net sales of Vascepa in Canada"

In addition

"Amarin Corporation Plc says terms of agreement include up-front and milestone payments to Amarin of up to U.S. $65.0 million" (not bad for just Canada)

"Amarin Corporation Plc says HLS will be responsible for regulatory and commercialization activities and associated costs"

https://www.reuters.com/article/brief-amarin-and-hls-therapeutics-announ-idUSFWN1M607Y

CaptBeer

08/07/21 8:08 AM

#349733 RE: sts66 #349698

I haven't put a pencil to the HLS royalty calculations yet, but I believe "The norm" for these things is a peak of 16%. We'll get there in Canada and ROW eventually.